AAUM (Average Assets Under Management) of ₹29,428.11 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Banks | 16.9% | 16.9% | ● +0.0% |
| Pharmaceuticals & Biotechnology | 11.0% | 11.6% | ▲ +0.6% |
| Finance | 8.4% | 8.2% | ▼ -0.2% |
| IT - Software | 6.5% | 6.6% | ▲ +0.1% |
| Auto Components | 4.4% | 4.5% | ● +0.0% |
| Automobiles | 4.0% | 3.9% | ▼ -0.1% |
| Retailing | 3.6% | 3.6% | ● -0.1% |
| Insurance | 3.1% | 3.0% | ● 0.0% |
| Petroleum Products | 2.8% | 2.7% | ▼ -0.1% |
| Healthcare Services | 2.7% | 2.6% | ▼ -0.1% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Banks | 16.9% | 17.0% | ● +0.0% |
| Pharmaceuticals & Biotechnology | 11.6% | 12.0% | ▲ +0.3% |
| Finance | 8.2% | 7.9% | ▼ -0.2% |
| IT - Software | 6.6% | 6.3% | ▼ -0.3% |
| Auto Components | 4.5% | 4.5% | ● 0.0% |
| Automobiles | 3.9% | 3.7% | ▼ -0.1% |
| Retailing | 3.6% | 3.6% | ● 0.0% |
| Insurance | 3.0% | 3.0% | ● -0.1% |
| Petroleum Products | 2.7% | 2.7% | ● 0.0% |
| Chemicals & Petrochemicals | 2.5% | 2.6% | ● +0.1% |
Comparing Aug 2026 → Sep 2026
| # | Stock | Sector | Weight (Sep 2026) |
|---|---|---|---|
| 1 | GE Vernova T&D India Limited ₹27.91 Cr |
Electrical Equipment | 0.10% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | HDFC Bank Limited ₹1,039.29 Cr |
Banks | 3.43% | 3.64% | +0.21% |
| 2 | Sterlite Technologies Limited ₹145.58 Cr |
Telecom - Equipment & Accessories | 0.40% | 0.51% | +0.11% |
| 3 | Redington Limited ₹158.85 Cr |
Commercial Services & Supplies | 0.46% | 0.56% | +0.10% |
| 4 | Gland Pharma Limited ₹405.92 Cr |
Pharmaceuticals & Biotechnology | 1.33% | 1.42% | +0.09% |
| 5 | Bandhan Bank Limited ₹165.14 Cr |
Banks | 0.50% | 0.58% | +0.08% |
| 6 | Kotak Mahindra Bank Limited ₹350.86 Cr |
Banks | 1.16% | 1.23% | +0.07% |
| 7 | Ajanta Pharma Limited ₹324.87 Cr |
Pharmaceuticals & Biotechnology | 1.07% | 1.14% | +0.07% |
| 8 | Bharti Airtel Limited ₹510.65 Cr |
Telecom - Services | 1.74% | 1.79% | +0.05% |
| 9 | ICICI Lombard General Insurance Company Limited ₹119.06 Cr |
Insurance | 0.37% | 0.42% | +0.05% |
| 10 | Aurobindo Pharma Limited ₹361.16 Cr |
Pharmaceuticals & Biotechnology | 1.22% | 1.27% | +0.05% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | PB Fintech Limited ₹78.20 Cr |
Financial Technology (Fintech) | 0.45% | 0.27% | -0.18% |
| 2 | Fortis Healthcare Limited ₹364.47 Cr |
Healthcare Services | 1.42% | 1.28% | -0.14% |
| 3 | ICICI Bank Limited ₹1,044.25 Cr |
Banks | 3.79% | 3.66% | -0.13% |
| 4 | Max Financial Services Limited ₹357.36 Cr |
Insurance | 1.35% | 1.25% | -0.10% |
| 5 | L&T Finance Limited ₹198.15 Cr |
Finance | 0.79% | 0.69% | -0.10% |
| 6 | Mahindra & Mahindra Financial Services Limited ₹319.30 Cr |
Finance | 1.21% | 1.12% | -0.09% |
| 7 | Infosys Limited ₹298.23 Cr |
IT - Software | 1.12% | 1.04% | -0.08% |
| 8 | Maruti Suzuki India Limited ₹351.17 Cr |
Automobiles | 1.31% | 1.23% | -0.08% |
| 9 | Shriram Finance Limited ₹316.26 Cr |
Finance | 1.18% | 1.11% | -0.07% |
| 10 | IndusInd Bank Limited ₹339.61 Cr |
Banks | 1.26% | 1.19% | -0.07% |
241 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹1,044.25 Cr |
Banks |
3.66%
|
|
| 2 |
₹1,039.29 Cr |
Banks |
3.64%
|
|
| 3 |
₹557.83 Cr |
Banks |
1.95%
|
|
| 4 |
₹510.65 Cr |
Telecom - Services |
1.79%
|
|
| 5 |
₹406.69 Cr |
Petroleum Products |
1.42%
|
|
| 6 |
₹405.92 Cr |
Pharmaceuticals & Biotechnology |
1.42%
|
|
| 7 |
₹403.96 Cr |
Banks |
1.42%
|
|
| 8 |
₹370.48 Cr |
Realty |
1.30%
|
|
| 9 |
₹364.47 Cr |
Healthcare Services |
1.28%
|
|
| 10 |
₹361.16 Cr |
Pharmaceuticals & Biotechnology |
1.27%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.